iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Stock Holdings Decreased by Massachusetts Wealth Management

Massachusetts Wealth Management lowered its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 1.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,550 shares of the company’s stock after selling 285 shares during the quarter. Massachusetts Wealth Management owned 0.14% of iShares U.S. Pharmaceuticals ETF worth $1,027,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in IHE. McElhenny Sheffield Capital Management LLC purchased a new position in iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at about $18,942,000. Aptus Capital Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at approximately $12,165,000. Rockport Wealth LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth approximately $12,091,000. Concord Investment Counsel Inc. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 1st quarter valued at $3,880,000. Finally, Southern Capital Advisors LLC grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 2.4% during the 2nd quarter. Southern Capital Advisors LLC now owns 39,832 shares of the company’s stock valued at $2,642,000 after acquiring an additional 948 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 0.1 %

IHE stock traded up $0.08 during mid-day trading on Friday, hitting $70.23. The stock had a trading volume of 4,240 shares, compared to its average volume of 60,737. iShares U.S. Pharmaceuticals ETF has a 1-year low of $55.36 and a 1-year high of $72.94. The company has a fifty day moving average of $71.21 and a 200 day moving average of $68.04. The stock has a market capitalization of $709.32 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.